Atlas Trials

Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMR

Clinical trial NCT07294495 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07294495
Sponsor
Shanghai East Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HCM - Hypertrophic Cardiomyopathy
Start date
2026-01-07
Primary completion
2028-12-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.